-
Views
-
Cite
Cite
Quinn T. Ostrom, Haley Gittleman, Paul Farah, Annie Ondracek, Yanwen Chen, Yingli Wolinsky, Nancy E. Stroup, Carol Kruchko, Jill S. Barnholtz-Sloan, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010, Neuro-Oncology, Volume 15, Issue suppl_2, November 2013, Pages ii1–ii56, https://doi.org/10.1093/neuonc/not151
- Share Icon Share
Extract
Introduction
The objective of CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010 is to provide a current comprehensive review of the descriptive epidemiology of primary brain and central nervous system (CNS) tumors in the United States population. The Central Brain Tumor Registry of the United States (CBTRUS) obtained data on all newly diagnosed primary brain and CNS tumors from the Centers for Disease Control and Prevention (CDC), National Program of Cancer Registries (NPCR) and the National Cancer Institute (NCI), Surveillance, Epidemiology and End Results (SEER) program for diagnosis years 2006-2010. Incidence counts and rates of primary malignant and non-malignant brain and CNS tumors are documented by histology, gender, age, race, and Hispanic ethnicity. Mortality and relative survival rates for selected malignant histologies calculated using SEER data for the period 1995-2010 are also presented.
Background
The Central Brain Tumor Registry of the United States (CBTRUS) is a unique professional research organization that focuses exclusively on providing quality statistical data on population-based primary brain and CNS incident tumors in the United States. CBTRUS was incorporated as a nonprofit 501 (c) 3 with a founding and sustaining grant from the Pediatric Brain Tumor Foundation in 1992 following a two-year study conducted by the American Brain Tumor Association to determine the feasibility of a central registry for all primary brain and CNS tumor cases in the United States. Until that time, standard data reporting in the United States had been limited to malignant cases only.